CPA
APYX icon

Cowen Prime Advisors’s Apyx Medical APYX Stock Holding History

Cowen Prime Advisors’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$3.05M Buy
605,682
+3,500
+0.6% +$17.7K 1.05% 23
2023
Q1 		$2.05M Sell
602,182
-4,100
-0.7% -$12K 0.82% 30
2022
Q4 		$1.42M Buy
606,282
+338,517
+126% +$1.03M 0.58% 37
2022
Q3 		$1.2M Hold
267,765
– – 0.69% 31
2022
Q2 		$1.57M Buy
267,765
+13,906
+5% +$71.3K 0.89% 32
2022
Q1 		$1.66M Buy
253,859
+2,100
+0.8% +$20.7K 0.7% 34
2021
Q4 		$3.23M Hold
251,759
– – 1.1% 22
2021
Q3 		$3.49M Buy
251,759
+2,800
+1% +$29.5K 1.3% 18
2021
Q2 		$2.57M Hold
248,959
– – 0.93% 29
2021
Q1 		$2.4M Buy
248,959
+13,000
+6% +$130K 0.91% 30
2020
Q4 		$1.7M Sell
235,959
-2,010
-0.8% -$13.3K 0.75% 28
2020
Q3 		$1.12M Sell
237,969
-29,796
-11% -$148K 0.55% 38
2020
Q2 		$1.57M Buy
267,765
+8,051
+3% +$33.5K 0.89% 32
2020
Q1 		$932K Sell
259,714
-25,700
-9% -$173K 0.57% 40
2019
Q4 		$2.42M Buy
285,414
+11,509
+4% +$83.1K 1.1% 22
2019
Q3 		$1.85M Buy
273,905
+2,300
+0.8% +$16.3K 0.96% 28
2019
Q2 		$1.82M Sell
271,605
-19,600
-7% -$107K 0.88% 30
2019
Q1 		$1.84M Sell
291,205
-39,345
-12% -$304K 0.95% 30
2018
Q4 		$2.14M Buy
330,550
+24,845
+8% +$150K 1.29% 23
2018
Q3 		$2.17M Sell
305,705
-42,388
-12% -$236K 1.01% 33
2018
Q2 		$1.51M Buy
348,093
+32,636
+10% +$120K 0.75% 39
2018
Q1 		$937K Buy
315,457
+20,416
+7% +$52.5K 0.52% 49
2017
Q4 		$767K Buy
295,041
+120,871
+69% +$377K 0.37% 52
2017
Q3 		$589K Sell
174,170
-75,470
-30% -$195K 0.28% 55
2017
Q2 		$617K Buy
249,640
+167,862
+205% +$413K 0.28% 52
2017
Q1 		$218K Buy
81,778
+31,378
+62% +$104K 0.11% 75
2016
Q4 		$181K Buy
50,400
+1,300
+3% +$5.79K 0.1% 83
2016
Q3 		$256K Buy
49,100
+40,000
+440% +$130K 0.12% 101
2016
Q2 		$15K Buy
+9,100
New +$15.8K 0.01% 183

Other funds holding APYX

ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cowen Prime Advisors's APYX Position: Q2 2023 in Review

Cowen Prime Advisors increased its Apyx Medical (APYX) stake by 0.58% in Q2 2023, buying an estimated $17.7K and bringing the position to 605,682 shares worth $3.05M. The position accounts for 1.05% of the portfolio, ranked #23.

Cowen Prime Advisors first reported a position in APYX in Q2 2016 and has held it in 29 quarters since. The position peaked at $3.49M in Q3 2021. 56 funds tracked by Wall St. Rank hold APYX as of Q2 2023.

  • Cowen Prime Advisors held 605,682 shares of Apyx Medical worth $3.05M as of Q2 2023.
  • Cowen Prime Advisors bought 3,500 Apyx Medical shares in Q2 2023, an estimated $17.7K.
  • Apyx Medical made up 1.05% of Cowen Prime Advisors's portfolio in Q2 2023, its #23 holding.
  • Cowen Prime Advisors first reported a position in Apyx Medical in Q2 2016 and has held it in 29 quarters since.
  • Cowen Prime Advisors's Apyx Medical position peaked at $3.49M in Q3 2021.
  • 56 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2023.

Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.